iBio, Inc. (IBIO)
NASDAQ: IBIO · Real-Time Price · USD
1.900
-0.030 (-1.55%)
May 29, 2026, 4:00 PM EDT - Market closed
iBio, Inc. Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 0.3 | 0.4 | 0.23 | - | 1.88 | 2.37 | |
Revenue Growth (YoY) | -20.00% | 77.78% | - | - | -20.54% | 44.75% |
Cost of Revenue | - | - | - | - | - | 1.46 |
Gross Profit | 0.3 | 0.4 | 0.23 | - | 1.88 | 0.91 |
Selling, General & Admin | 14.95 | 10.69 | 11.67 | 19.02 | 21.75 | 22.03 |
Research & Development | 14.31 | 8.31 | 5.19 | 10.33 | 9.83 | 9.99 |
Total Operating Expenses | 29.26 | 19 | 16.86 | 29.34 | 31.58 | 32.02 |
Operating Income | -28.96 | -18.6 | -16.63 | -29.34 | -29.7 | -31.11 |
Interest Income | 1.5 | 0.44 | 0.36 | 0.21 | 0.18 | 0.15 |
Interest Expense | -0.14 | -0.21 | -0.17 | -0.08 | - | -2.45 |
Other Non-Operating Income (Expense) | 1.35 | 0.23 | 1 | -0.1 | 0.18 | 10.2 |
Total Non-Operating Income (Expense) | 2.71 | 0.45 | 1.19 | 0.03 | 0.37 | 7.9 |
Pretax Income | -26.25 | -18.15 | -15.44 | -29.31 | -29.33 | -23.21 |
Net Income | -5.16 | -18.38 | -24.91 | -65.01 | -50.39 | -23.47 |
Minority Interest in Earnings | - | - | - | - | -0 | -0.01 |
Net Income Attributable to Preferred Dividends | - | - | - | - | -0.09 | -0.26 |
Earnings From Discontinued Operations | - | - | -9.46 | -35.7 | -20.79 | - |
Net Income to Common | -5.16 | -18.38 | -24.91 | -65.01 | -50.39 | -23.47 |
Shares Outstanding (Basic) | 72 | 10 | 4 | 1 | 0 | 0 |
Shares Outstanding (Diluted) | 72 | 10 | 4 | 1 | 0 | 0 |
Shares Change (YoY) | 690.12% | 174.05% | 525.98% | 40.35% | 11.45% | 211.53% |
EPS (Basic) | -0.57 | -1.75 | -6.50 | -106.19 | -115.60 | -60.00 |
EPS (Diluted) | -0.57 | -1.75 | -6.50 | -106.19 | -115.60 | -60.00 |
Shares Outstanding | 34.54 | 19.35 | 8.62 | 1.02 | 0.44 | 0.44 |
Free Cash Flow | -22.17 | -15.32 | -18.55 | -36.17 | -44.81 | -34.98 |
Free Cash Flow Per Share | -0.31 | -1.46 | -4.84 | -59.11 | -102.76 | -89.42 |
Gross Margin | 100.00% | 100.00% | 100.00% | - | 100.00% | 38.34% |
Operating Margin | -9653.00% | -4650.50% | -7392.89% | - | -1576.27% | -1312.15% |
Profit Margin | -1721.00% | -4594.25% | -6863.56% | - | -1566.51% | -979.04% |
FCF Margin | -7388.33% | -3830.00% | -8246.22% | - | -2378.45% | -1475.50% |
EBITDA | -27.89 | -17.48 | -15.38 | -27.96 | -26.21 | -28.7 |
EBITDA Margin | -9298.00% | -4369.00% | -6837.33% | - | -1390.98% | -1210.33% |
EBIT | -28.96 | -18.6 | -16.63 | -29.34 | -29.7 | -31.11 |
EBIT Margin | -9653.00% | -4650.50% | -7392.89% | - | -1576.27% | -1312.15% |